Clover Health Investments (CLOV) Cash from Investing Activities (2020 - 2026)

Clover Health Investments (CLOV) has 7 years of Cash from Investing Activities data on file, last reported at -$5.1 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 156.75% year-over-year to -$5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.9 million (down 3300.65% YoY) and the FY2025 annual result came in at $4.1 million, up 621.42% from the prior year.
• Cash from Investing Activities grew to -$5.1 million in Q1 2026, from -$35.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $89.4 million in Q2 2022 to a low of -$43.4 million in Q3 2022.
• A 5-year average of $13.8 million and a median of $8.9 million in 2025 frame the typical range for Cash from Investing Activities.
• The widest YoY moves for Cash from Investing Activities: up 617.92% in 2025, down 2331.9% in 2025.
• Tracing CLOV's Cash from Investing Activities over 5 years: stood at $12.7 million in 2022, then soared by 561.05% to $83.7 million in 2023, then tumbled by 101.72% to -$1.4 million in 2024, then sank by 2331.9% to -$35.0 million in 2025, then jumped by 85.52% to -$5.1 million in 2026.
• The last three Cash from Investing Activities figures came in at -$5.1 million (Q1 2026), -$35.0 million (Q4 2025), and -$5.4 million (Q3 2025), per Business Quant data.